BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 12679120)

  • 1. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation.
    Lee JH; Lee KH; Kim S; Lee JS; Kim SH; Kwon SW; Kim WK
    Bone Marrow Transplant; 2000 Jan; 25(2):179-84. PubMed ID: 10673677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
    Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
    Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch.
    Scholl S; Klink A; Mügge LO; Schilling K; Höffken K; Sayer HG
    Transfusion; 2005 Oct; 45(10):1676-83. PubMed ID: 16181220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.
    Rowley SD; Liang PS; Ulz L
    Bone Marrow Transplant; 2000 Oct; 26(7):749-57. PubMed ID: 11042656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo adsorption of isohemagglutinins with fresh frozen plasma in major ABO-incompatible bone marrow transplantation.
    Webb IJ; Soiffer RJ; Andersen JW; Cohen CA; Freeman A; Sugrue M; Ritz J; Anderson KC
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):267-72. PubMed ID: 9450922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [ABO-incompatible allogeneic bone marrow transplantation].
    Xu L; Guo N; Wang S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):413-5. PubMed ID: 11721421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our first experience of transfusion support in allogenic bone marrow transplantations.
    Fregatova L; Volkova O; Platonova G; Afanasiev B
    Beitr Infusionsther Transfusionsmed; 1994; 32():445-7. PubMed ID: 9422124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte repopulation after major ABO incompatible transplantation with lymphocyte-depleted bone marrow.
    Bär BM; Van Dijk BA; Schattenberg A; de Man AJ; Kunst VA; de Witte T
    Bone Marrow Transplant; 1995 Dec; 16(6):793-9. PubMed ID: 8750272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of double-filtration plasmapheresis in major ABO-incompatible unrelated bone marrow transplantation].
    Huang T; Sun J; Liu J; Liu QF; Men FY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1438-40. PubMed ID: 16305976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow transplantation with major ABO incompatibility. Experience at the bone marrow transplantation unit of the Center of Lisbon at the IPOFG].
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1993 Feb; 6(2):79-81. PubMed ID: 8488766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the ABO incompatibility a risk factor in bone marrow transplantation?
    Rozman P; Kosir A; Bohinjec M
    Transpl Immunol; 2005 Aug; 14(3-4):159-69. PubMed ID: 15982558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pure red cell aplasia after allogeneic transplantation of ABO incompatible hematopoietic stem cells].
    Bullorsky E; Shanley C; Stemmelin G; Ceresetto J; Rabinovich O
    Medicina (B Aires); 2002; 62(6):575-7. PubMed ID: 12532694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Administration of haptoglobin in ABO incompatible bone marrow transplantation].
    Ito M; Imoto S; Nakagawa T; Kai S; Hara H
    Rinsho Ketsueki; 1990 Oct; 31(10):1716-20. PubMed ID: 2255063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.